Objective: To test the association between small for gestational age and polymorphisms in the insulin gene in newborns and their mothers, as well as the effect of the parental transmission of haplotypes. Subjects: Pairs of healthy African-American full-term newborns (N ¼ 207) and mothers were recruited from Memphis TN and Jackson MS with birth weights ranging from 2210 to 4735 g. Methods: Six single nucleotide polymorphisms (SNPs) located in the insulin (INS) and insulin-like growth factor 2 (IGF2)genes were genotyped in mothers and newborns. Haplotypes composed of three SNPs in the 5 0 region of the INS-IGF2 locus were computationally inferred. Odds ratios for risk of small for gestational age (SGA) birth were calculated for individual SNPs and inferred haplotypes in the newborns and in the mothers using logistic regression. For 162 mother -newborn pairs the parental transmission of the haplotypes could be inferred, and the risks for SGA birth were calculated for the three common haplotypes in this sample. Results: Three INS SNPs exhibited significant association with risk for SGA birth. The SNP alleles associated with increased risk for SGA were opposite in the maternal and newborn genomes, implying opposing influences on the rate of fetal growth. Consistent with these results, haplotypes composed of complementary nucleotide sequences (CAC at rs3842738, rs689 and rs3842748, respectively, in the newborn versus GTG in the mother) were significantly associated with risk for SGA birth. In analyses of haplotypes according to parental transmission, the same trend in risk for SGA was observed for both maternally and paternally transmitted haplotypes, although a significant difference in risk was observed only for paternally transmitted haplotypes. Conclusion: Polymorphisms near the 5 0 end of the INS-IGF2 locus are significantly associated with risk for SGA birth with a major effect due to the paternally transmitted haplotype, which is preferentially expressed due to imprinting.
Introduction
Reduced birth weight is a major risk factor for illness in the neonatal period and throughout life, with the smallest 8% of infants accounting for 69% of infant deaths. 1 Term, low birth weight infants are at least five times more likely to die in the first year 2 and are second only to premature infants in their rates of morbidity [3] [4] [5] [6] and mortality. 7 Small newborns have an increased risk of several adverse outcomes, especially cerebral palsy. As adults, individuals born small for gestational age (SGA) are at elevated risk of pre-eclampsia, 8 gestational diabetes, 9 hypertension, 10 non-insulin-dependent diabetes, 11, 12 and cardiovascular disease, 13 although these associations are controversial. 14, 15 The cause of the statistically significant and frequently replicated finding of an inverse relationship between birth size and adult predisposition to chronic disease has been heavily debated. There are two principal explanations for the relationship, which are not mutually exclusive and may both explain part of the birth weight-disease association. The 'fetal origins' 16 hypothesis argues that an inadequate uterine environment (that is, poor nutrition, placental insufficiency) results in long-term alterations in organ structure and function and hormonal milieu that make the individual more susceptible to disease. The main alternative explanation for the birth weight-disease association is the existence of genetic etiological factors common to both reduced fetal growth and disease predisposition. The shared genetic etiological factor hypothesis is supported by a very strong and statistically significant inverse correlation between paternal mortality and offspring birth size that is only slightly weaker than that between maternal mortality and offspring birth size, 17, 18 even after adjusting for shared lifestyle risk factors (that is, smoking) and socioeconomic status. The strong negative correlation between paternal mortality and birth size indicates that there may be a connection between disease-predisposing genetic variants and reduced fetal size, in addition to effects from the intrauterine environment. There is compelling evidence for a significant genetic component to fetal growth control. For example, even after adjustment for parental anthropometry, smoking, prenatal care and education, a man who was SGA is 3.5 times more likely to have an SGA child, and woman who was SGA is 4.7 times more likely to give birth to an SGA child. If both parents were SGA, the risk of an SGA child is 16.3 times greater, 19 implying a multiplicative effect. 21 estimated that about 46% of the predisposition to be delivered SGA is due to genetic factors, with maternal and paternal components of 27.5 and 18.5%, respectively. Consistent with this recent research, SGA births tend both to cluster in families and to recur in successive generations, [22] [23] [24] [25] [26] even after adjustment for parental anthropometry and socioeconomic status.
27
Insulin (INS) and insulin-like growth factor 2 (IGF2) undergo imprinting, with preferential expression of the paternal allele in some tissues, particularly the yolk sac 28 and placenta. 29 The level of expression of both genes appears to be strongly influenced by the variable number of tandem repeats (VNTR) polymorphism upstream of the insulin gene. The presence of the smaller class I alleles (o64 repeats) is associated with increased expression of insulin and IGF2 in the fetal pancreas 30, 31 and placenta and in young obese individuals. 32 The class I alleles of the INS VNTR have been associated with type 1 diabetes susceptibility 33 and a specific association has been found between paternally transmitted alleles and childhood obesity. 34 Class III (4140 repeats) alleles exhibit a controversial association with type 2 diabetes predisposition, with some data supporting association with paternally transmitted alleles, 35 III/III homozygosity, 36 or no association at all. 37 Owing to a very high level of linkage disequilibrium (X94% concordance across populations 38, 39 ) between the A/T single nucleotide poly- In this study, we investigated the association between small for gestational age birth (defined as o2540 g at term) and SNP variation at six sites in the INS and IGF2 genes in African-American subjects. We tested for association with SNP and haplotype genotypes in both the newborns and mothers and with the parental transmission of insulin haplotypes.
Materials and methods

Subjects
Healthy African-American women with uncomplicated pregnancies were recruited upon admission for delivery at the University of Mississippi Medical Center (Jackson, MS) and University of Tennessee Health Science Center (Memphis). The design and purpose of the study were explained to subjects during early labor (less than 5 cm dilation) and signed informed consent was obtained at that time to avoid recruitment of subjects during the distress of advanced labor, as is the standard protocol at the participating hospitals. Only subjects who delivered healthy newborns were retained in the study. Inclusion criteria were: singleton pregnancy, 436 weeks gestation, 18-35 years old. Exclusion criteria were chosen to eliminate a large number of additional contributing factors to birth weight variation and included, among others: diabetes (type 1, type 2, gestational), hypertension/vascular disease, pre-eclampsia, autoimmune disease, infectious disease (that is, hepatitis, HIV), sickle-cell disease, uterine infection, illicit drug use, smoking and birth defects. The following maternal characteristics potentially related to newborn size were recorded: parity, age, BMI and weight gain during pregnancy ( Table 1) . The Institutional Review Boards of the respective institutions approved this study.
Genotyping
Cord blood, maternal blood and placental tissue were collected at delivery. DNA was extracted from maternal and Paternal insulin haplotypes and birth weight RM Adkins et al umbilical cord (fetal) blood. The primary criterion for selecting single nucleotide polymorphisms (SNPs) for genotyping was previous association with diabetes predisposition, birth weight, or postnatal obesity (rs689, rs3842748, rs3842756; Figure 1 , Table 2 Logistic regression was used to determine the relative risk of the newborn being small for gestational age (SGA) associated with each maternal or newborn SNP genotype, adjusted for potential confounders. In our sample, babies were considered small for gestational age if their birth weight Z-score was more than 1 s.d. below the mean (ZoÀ1). In our sample, this corresponds to a maximum birth weight of 2540 g at 37 weeks, which conforms to the usual clinical classification of SGA as less than 2500 g at term and also matches the lowest eight percentile of births nationally. 1 Thirty-five of the 207 babies met this criterion. Potential confounders included maternal age, maternal overweight, parity and weight gain during pregnancy. Maternal overweight was defined as BMI in excess of 25.0, in accordance with World Health Organization criteria. In determining if our sample size was sufficient for analyses we assumed a twotailed level of significance of 0.05 and a power of 80%. With 226 subjects split equally between two groups (for example, having 0 copies of an allele versus 1 or 2 copies) we can detect a difference in the frequency of small for gestational age status of 10 versus 25%. In our findings below, we have a similar sample size and frequency difference for those SNPs found to be significant. Genotypes for SNPs or haplotypes were adjusted for confounders when testing for a significant association with being small for gestational age. To determine the risk associated with the less frequent (minor) allele at each locus, SNPs were coded into two classes: 1 or 2 copies of the minor allele versus 0 copies.
For both the mothers and newborns, haplotypes were inferred for the SNPs individually exhibiting significant Paternal insulin haplotypes and birth weight RM Adkins et al association with SGA risk using the program SNPHAP. 53 Based on the individual SNP analyses, the haplotypes in the mothers and newborns who were expected to confer significantly lower risk were identified. Separately in the mothers and newborns, the risk of SGA birth was compared between individuals bearing the low-risk haplotype (one or two copies) versus individuals lacking the low-risk haplotype. Additionally, the contributions to SGA risk conferred by the maternal and newborn haplotypes were mutually adjusted for one another by combining mothers and newborns in the same regression model and performing the same contrast between low-risk and all other haplotypes. For 162 mother -newborn pairs, the maternal and paternal transmission of the newborn haplotypes could be unambiguously inferred based upon the maternal and newborn haplotype combinations. In 45 cases the parental transmission of the newborn haplotypes was ambiguous, and these mother -newborn pairs were excluded from analyses that distinguished the parent transmitting each haplotype. Logistic regression was used to determine the relative risk for SGA associated with each newborn haplotype, according to which parent transmitted the haplotype. In both the maternal and paternal haplotype analyses we used haplotype CAC (the haplotype with the lowest proportion of SGA newborns) as the referent.
Results
SNP analyses
Maternal age, parity and weight gain during pregnancy were non-significant (P40.2) predictors of SGA, leaving maternal overweight as the only significant non-genetic variable related to SGA (Spearman's rank correlation for maternal BMI and birth weight Z ¼ 0.21, Po0.01). None of the maternal SNP genotypes was significant predictors of maternal overweight in regression (P40.10). Among the mothers, presence of the minor allele (G) at rs3842738 was significantly associated with decreased risk of SGA (Table 3) . Among the newborns, reduced risk of SGA was significantly associated with the minor alleles at rs689 (allele A; also known as À23 HphI) and rs3842748 (allele C; also known as þ 805 DraIII). It should be noted that the less common (minor) alleles at SNPs rs689 and rs3842748 are opposite in African-Americans and Caucasians subjects when comparing these results to previous studies, most of which have been conducted among Caucasians subjects. None of the other three SNPs exhibited significant association with SGA in either the mothers or newborns.
Maternal and fetal genotypes for each of the three SNPs exhibiting significant association with SGA in mothers or newborns were combined in regression models with maternal overweight to identify the mutually adjusted contributions of the maternal and fetal genotypes (Table 4 ). In contrast to the separate maternal and fetal analyses, in the combined models the genotypes for both the mother and newborn are significant and suggest a stronger magnitude of effect than when the maternal and fetal genotypes are not adjusted for each other. Each SNP allele appears to have an opposite effect on the risk of SGA when present in the mother versus when present in the fetus. Specifically, alleles C at rs3842738, A at rs689 and C at rs3842748 in the fetus reduce the risk of SGA three-to fourfold in the presence of the opposite alleles in the mother.
Haplotype analyses
The patterns of variation at the three SNPs associated with size for gestational age are very highly correlated (D 0 X0.92). Therefore, it was possible to infer haplotypes computationally for those three sites in both mothers and newborns. Based on the individual SNP analyses, haplotype CAC at sites rs3842738, rs689 and rs3842748, respectively, was predicted to be associated with the lowest risk of SGA birth when present in the newborns, while its complement (GTG) was predicted to confer the lowest risk of SGA when present in the mothers. In both the newborns and their mothers, individuals bearing the predicted low-risk haplotype were found to have significantly lower frequency of SGA births (Table 5 ). Newborns bearing 1 or 2 copies of the CAC haplotype had a threefold reduced risk of SGA birth, and mothers bearing haplotype GTG had about a twofold reduced risk. When mothers and newborns were combined in the same model, the maternal and newborn contributions remained significant and were of greater magnitude. In the (Table 6 ), the risk of an SGA newborn was about two-to threefold greater for maternally transmitted haplotypes CTG and GTG compared to haplotype CAC, although this difference was not significant. For haplotypes inferred to have been paternally transmitted, the risk of an SGA newborn was nearly fourfold greater for haplotype CTG compared to CAC, and the risk of an SGA birth was about sevenfold greater for haplotype GTG relative to CAC, and this latter difference in paternally transmitted risk was significant. Regardless of parental transmission, the risk of an SGA birth is lowest when haplotype CAC is present in the newborn.
Discussion
These results are an important contribution to the ongoing controversy over the relationship among the rate of fetal growth, obesity, variation in the insulin gene and imprinting of the insulin-IGF2 locus. Almost all earlier studies on the relationship between variation in the insulin locus and fetal size have focused on European populations, with a much smaller amount of work devoted to other ethnicities. This is the first study of the relationship between variation in the insulin-IGF2 locus and fetal growth in African Americans.
In a cohort of 207 African-American mother -newborn pairs, we found a significant relationship between risk of SGA and genotype at three SNPs near the 5 0 end of the insulin-IGF2 locus (Table 3) . When mothers and newborns were analyzed separately, the minor allele of one SNP (G at rs3842738) demonstrated a twofold reduction in risk of SGA when present in the mother, while the minor alleles of two different SNPs (A at rs689 and C at rs3842748) exhibited threefold reductions in SGA risk when present in the newborn. When the effects of the genotypes of both the mother and newborn at each SNP were adjusted for one another in the same regression model (Table 4) , genotypes for all three SNPs were significant in both the mother and newborn. Additionally, the magnitude of effect for each SNP was greater than in individual models, with three-to fourfold changes in SGA risk. Most interestingly, the effect of each SNP allele was opposite in the mother and in the newborn. In the newborn, alleles C at rs3842738, A at rs689 and C at rs3842748 were associated with a reduced risk of SGA but were associated with increased risk of SGA when present in the mother. The implication of these results is that the presence of the opposite alleles in the mother and newborn amplifies the effect of each SNP in both the maternal and fetal genomes.
Based on the individual SNP analyses, inferred haplotype CAC at rs3842738, rs689 and rs3842748, respectively, was predicted to confer the lowest risk of SGA when present in the newborns, and we found a statistically significant threefold reduction in SGA risk for that newborn haplotype (Table 5) . Similarly, as predicted, the complement to that haplotype (GTG) was associated with a significant twofold reduced risk of SGA when present in the mother. When combined in the same regression model, the effect of both haplotypes became stronger, with the risk of SGA reduced fourfold when haplotype CAC is present in the newborn and Referent ¼ haplotype CAC; odds ratio for SGA status based on 162 unambiguous transmissions of specific haplotypes from parents to newborn. 28 and placenta. 29 Therefore, it is reasonable to suspect that the magnitude of effect of allelic variants in the INS-IGF2 locus may differ depending upon the gender of the parent transmitting the variant. For 162 of the mothernewborn pairs, we could unambiguously infer which of the three inferred haplotypes was transmitted by the mother and father (Table 6 ). Among maternally transmitted haplotypes, the proportion of SGA newborns was lowest (12.5%) when the mother transmitted haplotype CAC, with a two-to threefold higher, but non-significant, risk of SGA (20.2-23.3%) when haplotype CTG or GTG was inherited from the mother. This trend is opposite to what was observed in analyses of the risk associated with the haplotype composition of the mother (Table 5) . When haplotype CAC is present in the mother, the risk of SGA is highest, but when haplotype CAC is transmitted by the mother to the newborn, the risk of SGA is lowest. This indicates that the effect that the haplotype variants have on the rate of fetal growth differs depending on whether the haplotype is present in the mother or in the fetus. The risk of SGA associated with paternally transmitted haplotypes is consistent with the pattern observed for maternally transmitted haplotypes, but the magnitude of the effect is greater. When haplotype CAC is transmitted by the father, the proportion of SGA newborns has its lowest observed value (5.1%), with the risk of SGA being sevenfold and very significantly higher (27.3%) when haplotype GTG is inherited from the father. The greater magnitude of effect of paternally transmitted haplotypes is consistent with their predominant expression in a wide variety of fetal tissues.
Stead et al. 39 surveyed the haplotype diversity of the insulin locus in populations from the United Kingdom, Kazakhstan, Japan, Ivory Coast, Zimbabwe and Kenya. Based on this global survey, haplotype CAC of this study was predominantly in association with the shorter class I alleles of the upstream insulin VNTR in all populations, while haplotypes CTG and GTG are found predominantly with class III alleles. Haplotype GTG was found only within African populations. Consistent with our results, Lindsay et al. 38 found an increase in birth weight in Pima Native Americans bearing class I alleles, as determined by genotype at the À23 HphI site (rs689). Additionally, they observed an effect of almost exactly the same magnitude as that found in our AfricanAmerican cohort (B250 g; paternal haplotype CAC versus haplotype GTG, Table 6 ) for paternally transmitted alleles. Although the difference was not statistically significant, they found a small effect for maternally transmitted alleles (111 g). We found no meaningful difference in average birth weight among the maternally transmitted haplotypes, but we did observe a small difference in the proportion of SGA offspring that paralleled the trend among paternally transmitted haplotypes. Further evidence for a strong effect for paternally transmitted variants of the insulin locus was found by Le Stunff et al., 34 who determined that paternal transmission of class I alleles was associated with a predisposition to obesity in childhood. Overall, these results suggest that the insulin alleles inherited from the father have the strongest effect on fetal growth, and perhaps postnatal weight gain, but that the maternal alleles also exert an effect of smaller magnitude, which may be explained by their lack of expression in several fetal tissues. An association between greater birth weight and presence of class I VNTR alleles in the fetus is quite consistent with some previous evidence that these alleles are also associated with increased expression of INS and IGF2 in the fetal pancreas, placenta and in young obese individuals. [30] [31] [32] Increased expression of either of these proteins would be expected to increase fetal size, either directly via the INS and IGF1 receptors (with which IGF-II interacts) or through increased uptake of blood glucose and fat deposition (mediated by INS). Conversely, the association of class III alleles with lower birth weight is consistent with suggestive association of those alleles with predisposition to type 2 diabetes, 49 given that low birth weight is also associated with higher risk of type 2 diabetes. 11,12 Importantly, Huxtable et al. 35 found a significant paternal overtransmission of class III alleles to type 2 diabetic offspring, but no significant association when both maternal and paternal transmissions were considered together or for maternal transmissions alone. This is consistent with our finding of a strong influence of paternally inherited variants of the insulin locus.
Haplotype CAC is associated with the lowest risk of SGA when present in the fetus, regardless of whether the haplotype is transmitted by the mother or father. In contrast, the opposite trend is observed within the maternal genome, where the highest risk of SGA is conferred by haplotype CAC and the lowest risk by haplotype GTG. This seemingly contradictory pattern may be consistent with the normal physiology of pregnancy. Pregnancy is characterized by the development of insulin resistance and postprandial hyperglycemia, presumably with the purpose of increasing and sustaining the accessibility to the fetus of glucose, the primary energy source during fetal development. 54 It is perhaps significant that homozygosity for the class III VNTR alleles is associated with predisposition to polycystic ovary syndrome, 55 in which increased insulin resistance is a hallmark. Similarly, the class III alleles exhibit a controversial association with predisposition to type 2 diabetes, 36, 49 which is characterized by insulin resistance. This raises the possibility that presence of the class III allele in the maternal genome contributes to the insulin resistance that facilitates fetal growth. Our results are not the first demonstration of genetic variation influencing fetal and maternal insulin levels that Paternal insulin haplotypes and birth weight RM Adkins et al has an opposite effect on birth weight when present in the maternal versus fetal genome. Hattersley et al. 56 showed that rare mutations in the glucokinase gene produced an increase in fetal size when present in the mother, but a decrease in fetal size when present in the fetus. Glucokinase is key to the sensing of glucose by the pancreas. A defect in glucokinase in the mother would produce elevated glucose levels, which would facilitate fetal growth, while a defective fetal glucokinase gene would impair fetal sensing of elevated glucose levels and its consequent stimulation of insulin production, which would retard fetal growth. Our results, in conjunction with those of Hattersley et al., 56 provide further evidence that modification of maternal and fetal insulin levels is a powerful regulator of fetal growth. Unfortunately, the relationship between insulin gene variation and fetal growth is far from clear. Among Caucasian babies whose age-adjusted size changed by less than 0.67 s.d. upto 2 years of age, Dunger et al. 44 found a significant increase of about 250 g birth weight for babies bearing class III VNTR alleles, the opposite trend from what we observed. Interestingly, the trend reported by Dunger et al. 45 was not observed among babies with significant postnatal changes in size centile or in a later separate subcohort of the same large study, although an increased level of IGF-II in umbilical cord blood was found in III/III homozygotes. Additionally, no parent-of-origin effects were observed in the second subcohort. 45 In most Caucasian populations studied to date, no association has been found between birth weight and polymorphism in the INS-IGF2 locus. In three British cohorts, Mitchell et al. 48 did not find an association between INS VNTR size classes or evidence for parent-of-origin effects in the transmission of VNTR alleles. Similarly, Hansen et al. 37 found that in a study of Danish Caucasians there was no association between genotype for INS VNTR alleles or for paternal or maternal transmission of class III alleles and birth weight. However, they did not compare average birth weights between class I and class III alleles according to parental origin. Therefore, if birth weight did differ between paternally transmitted class I and III alleles, they would not have observed it. Finally, Bennett et al. 46 found no association between INS VNTR classes and birth size in a large Finnish cohort. However, they did not include parental genetic data and therefore could not test for paternal effects. It is not obvious why the same association between insulin polymorphism and birth size is observed in AfricanAmericans and Pima Native Americans but that in Caucasians either the opposite trend is observed or no association is found. One possible explanation is the occasional exaggeration of minor or spurious genetic associations in small sample sizes. 57 However, an equally plausible explanation is the existence of real differences in the pattern of variation and biological effect of the insulin locus among global populations. Non-Africans share a small proportion of the total number of haplotype lineages found among African populations. 39 Indeed, our haplotypes CTG and GTG are both found in conjunction with class III VNTR alleles, but haplotype GTG is unique to African populations and tags a distinct lineage of alleles. 39 Although the À23 HphI site is commonly used as a proxy for entire allele classes of the INS VNTR that are implicitly assumed to have similar biological effects, this masks a large amount of diversity that is known to exist not only among subclasses of the VNTR but also at many SNPs in the insulin-IGF2 locus. As an example, sublineages of the class I alleles have been demonstrated to differ in their relationship to circulating insulin levels.
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It should also be borne in mind that it is not only the VNTR that may exert an effect on the behavior of the INS-IGF2 locus. Indeed, Kralovicova et al. 59 found in several cultured human cell lines that the A allele at the À23 HphI site (a marker of class I VNTR alleles) influenced insulin mRNA splicing and resulted in transcripts with longer leader sequences and increased production of proinsulin, suggesting that the À23 site is itself functional. Future studies of association with INS-IGF2 locus polymorphism should include a wider survey of tag SNPs to allow better subtyping of INS-IGF2 haplotypes and multiple ethnicities to permit detection of differential effects among ethnicities due to those genetic differences. Based on our results, we have inferred that SNP variation upstream of the insulin gene confers opposite risks of small for gestational age birth when present in the mother or in the fetus and that the effect observed in newborns is primarily due to the alleles inherited from the father. However, in the complete absence of paternal genetic data we are unable to apply a formal test of parent-of-origin effects, such as a transmission disequilibrium test or a variance components test that conditions on both parental genotypes. Therefore, the possibility of confounding must be considered. 60 For example, the genotypes of the mothers and of the offspring are not independent, and this could produce a false appearance of direct maternal genetic effects. Specifically, if an allele promotes fetal growth when present in the fetus but has no effect when present in the mother, direct maternal genetic effects may still appear to be present. This is because a newborn that is large due to homozygosity for an allele has a 100% probability of having a mother bearing the allele, and a large heterozygous newborn has on average a 50% probability of having a mother bearing the causative allele. Compared to smaller newborns, the allele will be over-represented among mothers of large newborns, even though the allele exerts no direct effect through the mothers. However, it is difficult to envision a scenario in which the positive correlation between the maternal and fetal genotypes would produce our observations because the same allele appears to have opposite effects on risk for SGA when present in the mother or in the newborn. If the SNPs we have surveyed exerted their effect only within the mothers or within the newborns, we would expect an overrepresentation of the same allele in the larger newborns and in their mothers. Additionally, it is less plausible to exclude maternal genetic effects and to explain our results as solely
Paternal insulin haplotypes and birth weight RM Adkins et al the consequence of imprinting and the alleles inherited from the father. Under this scenario, the only way in which we would achieve our observations of opposite maternal and fetal genetic effects in the actual absence of maternal genetic effects would be if the maternal and paternal genotypes were negatively correlated. While it is impossible to exclude confounding as an explanation for our findings, alternative explanations appear less plausible.
